Evolus, Inc.

LSE:0K16 Stock Report

Market Cap: US$730.1m

Evolus Management

Management criteria checks 2/4

Evolus' CEO is David Moatazedi, appointed in May 2018, has a tenure of 6.67 years. total yearly compensation is $11.24M, comprised of 6.1% salary and 93.9% bonuses, including company stock and options. directly owns 0.016% of the company’s shares, worth $114.19K. The average tenure of the management team and the board of directors is 3.2 years and 6.7 years respectively.

Key information

David Moatazedi

Chief executive officer

US$11.2m

Total compensation

CEO salary percentage6.1%
CEO tenure6.7yrs
CEO ownership0.02%
Management average tenure3.2yrs
Board average tenure6.7yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has David Moatazedi's remuneration changed compared to Evolus's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$55m

Jun 30 2024n/an/a

-US$53m

Mar 31 2024n/an/a

-US$60m

Dec 31 2023US$11mUS$688k

-US$62m

Sep 30 2023n/an/a

-US$63m

Jun 30 2023n/an/a

-US$66m

Mar 31 2023n/an/a

-US$72m

Dec 31 2022US$4mUS$597k

-US$74m

Sep 30 2022n/an/a

-US$79m

Jun 30 2022n/an/a

-US$79m

Mar 31 2022n/an/a

-US$71m

Dec 31 2021US$4mUS$572k

-US$47m

Sep 30 2021n/an/a

-US$139m

Jun 30 2021n/an/a

-US$131m

Mar 31 2021n/an/a

-US$137m

Dec 31 2020US$3mUS$527k

-US$163m

Sep 30 2020n/an/a

-US$67m

Jun 30 2020n/an/a

-US$82m

Mar 31 2020n/an/a

-US$99m

Dec 31 2019US$2mUS$550k

-US$90m

Sep 30 2019n/an/a

-US$88m

Jun 30 2019n/an/a

-US$73m

Mar 31 2019n/an/a

-US$52m

Dec 31 2018US$6mUS$362k

-US$47m

Compensation vs Market: David's total compensation ($USD11.24M) is above average for companies of similar size in the UK market ($USD1.46M).

Compensation vs Earnings: David's compensation has increased whilst the company is unprofitable.

CEO

David Moatazedi (46 yo)

6.7yrs

Tenure

US$11,240,447

Compensation

Mr. David Moatazedi is Independent Director at Biomerica Inc. from December 07, 2022. He has been the President, Chief Executive Officer and Director of Evolus, Inc. since joining it on May 6, 2018. Mr. Mo...

Leadership Team

NamePositionTenureCompensationOwnership
David Moatazedi
President6.7yrsUS$11.24m0.016%
$ 114.2k
Sandra Beaver
Chief Financial Officer2.3yrsUS$2.46m0.056%
$ 410.2k
Rui Avelar
Chief Medical Officer and Head of Research & Development11yrsUS$2.93m0.31%
$ 2.3m
Nareg Sagherian
Head of Global Investor Relations & Corporate Communicationsless than a yearno datano data
Jeffrey Plumer
General Counselno datano datano data
Kurt Knab
Vice President of Sales6.3yrsno datano data
Tomoko Yamagishi-Dressler
Chief Marketing Officer1.4yrsno data0.016%
$ 117.7k
Jessica Novak
Senior Vice President of Human Resources3.2yrsno datano data

3.2yrs

Average Tenure

46yo

Average Age

Experienced Management: 0K16's management team is considered experienced (3.2 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
David Moatazedi
President6.7yrsUS$11.24m0.016%
$ 114.2k
David Gill
Independent Director6.9yrsUS$256.03k0.043%
$ 317.1k
Simone Blank
Director7yrsUS$235.03k0.86%
$ 6.3m
Albert White
Independent Directorless than a yearno datano data
Vikram Malik
Chairman of the Board7yrsUS$271.03k0.37%
$ 2.7m
Karah Parschauer
Independent Director5.5yrsUS$249.03k0.049%
$ 360.2k
Brady Stewart
Independent Director3yrsUS$222.03k0.071%
$ 516.5k

6.7yrs

Average Tenure

54yo

Average Age

Experienced Board: 0K16's board of directors are considered experienced (6.7 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/05 06:24
End of Day Share Price 2025/01/03 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Evolus, Inc. is covered by 13 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Balaji PrasadBarclays
Balaji PrasadBarclays
Navann Ty DietschiBNP Paribas Exane